- Identification of Potential Key Biomarkers and Immune Infiltration in Oral Lichen Planus
Lou Geng et al, 2022, Disease Markers CrossRef - PARP1 promotes EGFR-TKI drug-resistance via PI3K/AKT pathway in non-small-cell lung cancer
Xianping Xu et al, 2024, Cancer Chemotherapy and Pharmacology CrossRef - Study on the activation of cell death mechanisms: in search of new therapeutic targets in glioblastoma multiforme
Ludovica Gaiaschi et al, 2023, Apoptosis CrossRef - Polyadenosine diphosphate-ribose polymerase inhibitors: advances, implications, and challenges in tumor radiotherapy sensitization
Yi Zhang et al, 2023, Frontiers in Oncology CrossRef - Cytoplasmic Shotgun Proteomic Points to Key Proteins and Pathways in Temozolomide-Resistant Glioblastoma Multiforme
Milan Teraiya et al, 2024, Journal of Proteome Research CrossRef - Anti-Proliferative Effects of E2F1 Suppression in Glioblastoma Cells
Paulo R.D.V. Godoy et al, 2021, Cytogenetic and Genome Research CrossRef - Advances in synthetic lethality modalities for glioblastoma multiforme
Seidu A. Richard, 2024, Open Medicine CrossRef - Novel therapeutic combinations with PARP inhibitors for small cell lung cancer: A bench-to-bedside review
Jiaqi Xiong et al, 2022, Seminars in Cancer Biology CrossRef